Evidence map›Paper›PMID 42056325›Full record

ArticleScientific reports2026

Constraint aware and uncertainty informed QSAR modeling of Tetrahymena pyriformis toxicity using physicochemical descriptors.

El-Sayed Khafagy, Amr Selim Abu Lila, Ahmed Al Saqr, Mahboubeh Pishnamazi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

El-Sayed KhafagyDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia.
Amr Selim Abu LilaDepartment of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il, 81442, Saudi Arabia.
Ahmed Al SaqrDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia.
Mahboubeh PishnamaziInstitute of Research and Development, Duy Tan University, Da Nang, Vietnam. mahboubehpishnamazi@duytan.edu.vn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional Quantitative Structure Activity Relationship (QSAR) models for predicting aquatic toxicity typically focus on accuracy at the expense of uncertainty awareness, physicochemical consistency, and chemical similarity leakage risks. Hence, the predictions are unstable when tested over different chemical spaces. This paper presents a machine-learning framework to predict the toxicity of Tetrahymena pyriformis based on a dataset of 1792 organic compounds whose 40-h growth inhibition (IGC50) values were experimentally determined and converted to pIGC50 for the models. The goal is to generate trustworthy and explainable results by using only eight molecular descriptors that are physicochemically relevant as model inputs. The proposed framework combines monotonicity-constrained learning, predictive uncertainty estimation, and intervention-inspired sensitivity analysis in one pipeline. The model’s reliability has been tested by cluster-aware data splitting, cross-validation, external testing, Y-scrambling, and applicability-domain assessment. The final method is capable of producing consistent, explainable, and risk-aware predictions and can be used as a reliability-centered basis for QSAR-initiated aquatic toxicity screening of chemically diverse compounds.

Indexed as

Aquatic toxicity predictionMonotonicity-constrained learningPhysicochemical descriptorsPredictive uncertainty quantificationTetrahymena pyriformis

Identifiers

PMID42056325
PMCPMC13219610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.